- Home
- SABS vs FLGC Comparison
SABS vs FLGC Comparison
Compare SABS & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- FLGC
- Stock Information
- Founded
- SABS 2014
- FLGC 2019
- Country
- SABS United States
- FLGC United States
- Employees
- SABS N/A
- FLGC N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- SABS Health Care
- FLGC Health Care
- Exchange
- SABS Nasdaq
- FLGC Nasdaq
- Market Cap
- SABS 19.0M
- FLGC 17.3M
- IPO Year
- SABS N/A
- FLGC 2021
- Fundamental
- Price
- SABS $1.25
- FLGC $0.54
- Analyst Decision
- SABS Strong Buy
- FLGC Strong Buy
- Analyst Count
- SABS 5
- FLGC 4
- Target Price
- SABS $11.40
- FLGC $5.67
- AVG Volume (30 Days)
- SABS 38.1K
- FLGC 119.8K
- Earning Date
- SABS 05-19-2025
- FLGC 05-13-2025
- Dividend Yield
- SABS N/A
- FLGC N/A
- EPS Growth
- SABS N/A
- FLGC N/A
- EPS
- SABS N/A
- FLGC N/A
- Revenue
- SABS $1,322,410.00
- FLGC $59,505,000.00
- Revenue This Year
- SABS N/A
- FLGC $4.28
- Revenue Next Year
- SABS $25.00
- FLGC N/A
- P/E Ratio
- SABS N/A
- FLGC N/A
- Revenue Growth
- SABS N/A
- FLGC N/A
- 52 Week Low
- SABS $1.11
- FLGC $0.53
- 52 Week High
- SABS $5.01
- FLGC $2.75
- Technical
- Relative Strength Index (RSI)
- SABS 31.17
- FLGC 30.09
- Support Level
- SABS $1.11
- FLGC $0.64
- Resistance Level
- SABS $1.80
- FLGC $0.72
- Average True Range (ATR)
- SABS 0.16
- FLGC 0.06
- MACD
- SABS -0.01
- FLGC -0.00
- Stochastic Oscillator
- SABS 18.42
- FLGC 5.67
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.